| 000 | 01356 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511181950.0 | ||
| 264 | 0 | _c19920619 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00686478 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaliberté, J | |
| 245 | 0 | 0 |
_aPotent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1992 |
||
| 300 |
_a7-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAzepines _xpharmacology |
| 650 | 0 | 4 |
_aCytarabine _xmetabolism |
| 650 | 0 | 4 |
_aCytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCytidine Deaminase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDeamination _xdrug effects |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aPyrimidine Nucleosides _xpharmacology |
| 650 | 0 | 4 |
_aTetrahydrouridine _xpharmacology |
| 700 | 1 | _aMarquez, V E | |
| 700 | 1 | _aMomparler, R L | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 30 _gno. 1 _gp. 7-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00686478 _zAvailable from publisher's website |
| 999 |
_c1381628 _d1381628 |
||